2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Gynaecological Cancers
In the realm of cancer research, gynecological cancers represent a multifaceted challenge. With diverse subtypes including ovarian, cervical, uterine, vaginal, and vulvar cancers, each presents distinct characteristics and complexities. Researchers focus on several fronts, from early detection methods like Pap smears and HPV vaccinations to innovative treatment modalities such as targeted therapies and immunotherapies. Personalized medicine, guided by genetic profiling, is revolutionizing treatment approaches, tailoring interventions to individual patients' molecular makeup. Additionally, advancements in minimally invasive surgery techniques improve patient outcomes and recovery times. Collaborative efforts between clinicians, scientists, and advocacy groups drive progress, emphasizing prevention, early diagnosis, and enhanced treatment strategies. Through continuous research endeavors, the quest to combat gynecological cancers persists, offering hope for improved survival rates and quality of life for affected individuals.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China